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mammography cancer preventive services, veterans are less likely to have had a 
mammogram in the past year controlling for a wide range of socio-demographic 
variables. There is no significant difference in women veterans and women non-vet-
erans and their utilization of pap smears in the 2011 data. ConClusions: Despite 
documented evidence in early cancer detection, take up rates for mammography 
and colonoscopy among US veterans appears lower than non veterans. Veterans may 
not be accessing the prevention services available to them in the VA and perhaps 
awareness and education can increase these rates in the future.
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objeCtives: To analyze cost savings for the first year of a rheumatoid arthritis 
(RA) pathway program. Cardinal Health collaborated with CareFirst BlueCross 
BlueShield to develop the first payer-sponsored RA pathway program in the 
United States. Private-practice rheumatologist participation was voluntary, but 
reimbursement enhancements were offered to mitigate cost of pathway adoption 
and compliance. A steering committee comprised of 12 participating physicians 
created the pathway, which included an obligatory use of a real-time decision 
support and data capture tool; use of disease-modifying antirheumatic drugs 
(DMARDs) as first-line treatment for at least 12 weeks prior to use of biologic 
agents; and a requirement that dose, schedule, and adjustments for biologic agents 
follow package label prescribing guidelines. Methods: 80 physicians in 37 prac-
tices participated in the program; 876 active treatment patients were accrued 
from 2/1/12-1/31/12. Claims data augmented and validated tool-data capture. A 
first month to last month trend design was used to calculate savings regarding 
the percentage of patients initially treated with DMARDs and the use of biologic 
agents by label dose and schedule. A matched control design was used to asses 
savings for site of care based on the percentage of patients who received office-
based versus hospital-based infusions among participating and nonparticipating 
community rheumatologists. Results: DMARD use increased by 7.4% over the 
first year contributing to a lower cost of care annualized at $1,069,790. Control 
of biologic “dose-creep” contributed $80,230 to further lowering cost annually. 
Average hospital facility costs per biologic infusion were near double that of 
community practice ($5000 vs $2500, respectively). Participating providers had 
80% fewer facility infusions than nonparticipating providers (11% vs 55%, respec-
tively). ConClusions: RA pathway algorithm-compliant prescribing behavior for 
DMARDs and biologics resulted in dramatic savings. Preserving community site of 
care represents a significant savings potential for RA management.
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objeCtives: Previous studies that have evaluated the association between mam-
mography screening and stage at breast cancer (BC) diagnosis had limitations 
because they did not analyze persistence to mammography screening and did not 
distinguish screening from diagnostic mammograms. The primary objective of this 
study is to determine the association between persistence to mammography screen-
ing and stage at BC diagnosis among elderly women. Methods: A retrospective 
cohort study was conducted using Surveillance, Epidemiology, End Results (SEER)-
Medicare database. The study population consisted of elderly women age > 70 diag-
nosed with incident BC in 2007 (N = 7,945). Persistence to mammography screening 
was measured as having at least three mammograms during the 5 years prior to BC 
diagnosis. A validated algorithm with very high sensitivity and specificity was used 
to distinguish between screening and diagnostic mammograms. Chi-square tests 
and multinomial logistic regressions were performed to analyze the association 
between persistence to mammography screening and stage of BC diagnosis, after 
controlling for predisposing, enabling, need, health care use, and external environ-
ment factors. Results: Overall, 45.4% of elderly women with incident BC were 
persistent to annual or biennial screening mammograms, 26.4% were not persistent 
to annual or biennial screening mammograms and 28.2% did not have any mam-
mogram. As compared to women who did not have any mammogram, women who 
were persistent to screening mammography were significantly more likely to be 
diagnosed at earlier stages. The adjusted odds ratios were: 44.96 (95%CI= 31.3-64.4), 
10.90 (95%CI= 8.1-14.6), and 3.40 (95%CI= 2.5-4.6) for insitu, local, and regional stages, 
respectively. ConClusions: Only a minority of elderly women were persistent 
to annual or biennial screening mammograms and persistence to mammography 
screening was associated with earlier BC disease stage. Interventions designed to 
promote persistent screening mammograms among elderly women are warranted.
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objeCtives: Patients new to therapy for chronic conditions often have poor medi-
cation adherence that can lead to adverse outcomes and higher medical costs. 
Previous studies have demonstrated the benefit of pharmacist interventions to 
improve adherence. The objective of this study is to evaluate the impact of a commu-
nity pharmacist telephone call program on medication adherence in patients new 
treatment patterns of patients with NETs, and future research should investigate 
the management strategy of different symptoms in this population and its impact 
on health care resource utilization and costs.
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objeCtives: This study of hospitalized Medicare beneficiaries with acute bacterial 
skin and skin structure infections (ABSSSI) diagnoses describes inpatient hospital 
cost and resource use by patients with primary ABSSSI infections. Methods: The 
study used Medicare Provider Analysis and Review (MedPAR) Files from 2011—2012 
containing claims for 313,646 patients in 2011 and 317,527 patients in 2012 with 
a primary ABSSSI diagnosis with Age ≥ 18 from a 100% sample of hospitalized 
Medicare beneficiaries during 2011-2012. Reimbursements were derived from 2012 
MedPAR data and costs were derived from 2010 Premier data, inflated (4.7%) to 2012 
using the October 2013 hospital producer price index (PPI) generated by the Bureau 
of Labor Statistics. Net reimbursement was analyzed by MS-DRG and LOS. The analy-
sis used regression modeling to determine factors correlated with LOS. Results: 
Median Charlson Comorbidity Index (CCI) was 3; patients tended to have more cel-
lulitis on the trunk, foot, and toe. The median LOS was three days. Sixteen percent 
of patients used the ICU/CCU. For MS-DRG 603 (Cellulitis without MCC), the most 
common MS-DRG comprising 61% of admissions, net reimbursement was positive 
when LOS ≤ 3 days, but 52% of admissions were projected to result in financial losses 
to the hospital. Age, non-minority status, Northeast census region, CCI, cellulitis on 
the leg and traumatic wound infection were correlated with longer LOS; diagnoses 
of erysipelas, diabetes without complications and drug abuse were correlated with 
shorter LOS. Median costs were $5,612. ConClusions: The median length of stay 
for Medicare patients is shorter than the indicated length of antibiotic drug treat-
ment for ABSSSI (7-10 days), implying that most patients complete treatment in 
ambulatory settings. Hospitalization cost is projected to be less than reimbursement 
for many of the most common type of ABSSSI patients.
PHS77
factORS ReLated wItH dIRect cOStS Of ReSIdentIaL mentaL HeaLtH 
SeRVIceS In SãO PauLO cIty, BRazIL: dOeS ReSIdent PROfILe affect 
cOStS?
Razzouk D, Sousa A, Cardoso A, Oliveira GG, Mari JJ
Universidade Federal de Sao Paulo, Sao Paulo, Brazil
objeCtives: Residential services costs have been associated with multiple variables 
such as resident psychiatric status and severity of symptoms, daily living skills, 
social behaviour problems, geographic region, service size, gender and age. In 2008, 
up to twenty full staffed homes were created in Sao Paulo city, in order to accommo-
date people discharged from psychiatric hospitals. Aims of this study were to esti-
mate the direct costs of staffed homes and also to explore the relationship between 
resident profile and services costs. Methods: We used a bottom-up approach for 
the estimation of direct costs according to public health service provider perspective. 
Direct costs included costs with accommodation, inpatient, outpatient and emer-
gency health services and treatment received in the previous month, in 147 subjects 
with mental disorders living in twenty full staffed homes during the year 2011. We 
evaluated resident profile (quality of life, social behaviour problems, psychiatric 
diagnosis, severity of symptoms, socio demographic characteristics) and pattern of 
health service use. Linear regression analysis was employed to verify the effect of 
resident profile on residential services costs. Results: Residential services costs 
corresponded to 89% of the total direct costs including accommodation, health care 
and medication, and of these, 62% were due to human resources costs, 8% to trans-
portation and house repairs and 7% to overhead. Residential costs were associated 
exclusively with geographic region, length of time living in psychiatric hospital and 
length of time living in residential service. Mean of residential costs per month per 
capita was U$1,750.00 (1U$= 2.00 R$-Brazilian currency). One-fourth to one-third 
of the sample presented good scores of autonomy, social behaviour and psychiatric 
status. ConClusions: Direct costs of residential services could be optimized if 
one-fourth of sample with good autonomy and appropriate social behaviour would 
be transferred to less expensive services like semi-staffed or not staffed homes.
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bACkgRound:: The utilization of cancer preventive care services including 
mammography, colonoscopy and pap smears in the United States remains low, 
despite their established success in reducing cancer deaths. Due to the harmful 
exposures during their service years veterans may have more negative health 
outcomes compared to nonveterans. The rising costs of cancer treatment and a 
focus on quality treatment require the public to understand how VA resources are 
being used and if they are providing high quality and effective care to our nations’ 
Veterans. objeCtives: To understand the difference in the utilization of preven-
tive services (specifically mammography, colonoscopy and pap smears) in the US 
between veterans and non veterans. Veterans have reported reasons for declining 
preventive services like previous negative results, no time to get tested, no risk 
factors, getting testing not being a priority, uninterested in knowing, and already 
infected. This paper assesses the difference in the utilization of preventive services 
with data from the Household Component (HC) of the Medical Expenditure Panel 
Survey (MEPS) from 2011. Methods: We attempted to understand the differences 
in utilization of cancer related preventative services between veterans and non-
veterans in 2011 using regression analyses. Results: For both colonoscopy and 
